ATE372772T1 - Retardiertes freigabesystem mit kontrollierter initialabgabe - Google Patents

Retardiertes freigabesystem mit kontrollierter initialabgabe

Info

Publication number
ATE372772T1
ATE372772T1 AT04396049T AT04396049T ATE372772T1 AT E372772 T1 ATE372772 T1 AT E372772T1 AT 04396049 T AT04396049 T AT 04396049T AT 04396049 T AT04396049 T AT 04396049T AT E372772 T1 ATE372772 T1 AT E372772T1
Authority
AT
Austria
Prior art keywords
release
core
retarded
controlled initial
delivery system
Prior art date
Application number
AT04396049T
Other languages
English (en)
Inventor
Teppo Riihimaeki
Original Assignee
Schering Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34932022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE372772(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Oy filed Critical Schering Oy
Application granted granted Critical
Publication of ATE372772T1 publication Critical patent/ATE372772T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Communication Control (AREA)
  • Vending Machines For Individual Products (AREA)
  • Adjustment And Processing Of Grains (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Selective Calling Equipment (AREA)
AT04396049T 2004-07-13 2004-07-13 Retardiertes freigabesystem mit kontrollierter initialabgabe ATE372772T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04396049A EP1629844B2 (de) 2004-07-13 2004-07-13 Retardiertes Freigabesystem mit kontrollierter Initialabgabe

Publications (1)

Publication Number Publication Date
ATE372772T1 true ATE372772T1 (de) 2007-09-15

Family

ID=34932022

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04396049T ATE372772T1 (de) 2004-07-13 2004-07-13 Retardiertes freigabesystem mit kontrollierter initialabgabe

Country Status (23)

Country Link
US (1) US7850986B2 (de)
EP (1) EP1629844B2 (de)
JP (1) JP4881861B2 (de)
KR (1) KR20070035032A (de)
CN (1) CN1984639A (de)
AT (1) ATE372772T1 (de)
AU (1) AU2005261682B2 (de)
BR (1) BRPI0513295A (de)
CA (1) CA2569542C (de)
DE (1) DE602004008912T3 (de)
DK (1) DK1629844T4 (de)
ES (1) ES2293193T5 (de)
IL (1) IL179846A (de)
MX (1) MX2007000433A (de)
NO (1) NO334931B1 (de)
NZ (1) NZ551823A (de)
PL (1) PL1629844T5 (de)
PT (1) PT1629844E (de)
RU (1) RU2412693C2 (de)
SI (1) SI1629844T1 (de)
UA (1) UA91337C2 (de)
WO (1) WO2006005794A1 (de)
ZA (1) ZA200610473B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE372772T1 (de) 2004-07-13 2007-09-15 Schering Oy Retardiertes freigabesystem mit kontrollierter initialabgabe
EP1781264B1 (de) * 2004-08-04 2013-07-24 Evonik Corporation Verfahren zur herstellung von abgabevorrichtungen und damit erhaltene vorrichtungen
US8124601B2 (en) * 2007-11-21 2012-02-28 Bristol-Myers Squibb Company Compounds for the treatment of Hepatitis C
WO2009085952A1 (en) 2007-12-20 2009-07-09 Brookwood Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US20100158980A1 (en) * 2008-12-18 2010-06-24 Casey Kopczynski Drug delivery devices for delivery of therapeutic agents
RU2429017C1 (ru) * 2010-04-05 2011-09-20 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Антиагрегантная активация в эксперименте in vitro
RU2428205C1 (ru) * 2010-04-05 2011-09-10 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ стимуляции условно-рефлекторной деятельности в модульном устройстве
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2734262B1 (de) * 2011-07-20 2018-02-28 Patrick F. Kiser Intravaginalen ringen zur wirkstofffreisetzung
KR102304995B1 (ko) 2012-01-18 2021-09-28 월드와이드 이노베이티브 헬쓰케어, 인코포레이티드 변형 가능한 폐쇄 피부 드레싱 키트 및 방법
AR089765A1 (es) 2012-01-23 2014-09-17 Bayer Oy Un sistema para el suministro de un farmaco
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN105310974B (zh) * 2014-08-01 2019-08-23 山东绿叶制药有限公司 罗替戈汀及其衍生物或其药用盐的植入剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
NZ217844A (en) 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
DE19975054I2 (de) 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
RU2088166C1 (ru) * 1993-08-10 1997-08-27 Педдер Валерий Викторович Способ контрацепции и устройство для его осуществления
DK0754032T3 (da) 1994-04-08 2002-04-02 Atrix Lab Inc Flydende frigivelsessammensætninger
US5492947A (en) * 1994-06-23 1996-02-20 Aspen Research Corporation Barrier material comprising a thermoplastic and a compatible cyclodextrin derivative
GB2290964A (en) 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
FI97947C (fi) 1994-09-27 1997-03-25 Leiras Oy Menetelmä lääkepreparaatin valmistamiseksi
GB9522403D0 (en) † 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6416778B1 (en) * 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
NZ330596A (en) * 1998-06-05 2001-02-23 Dec Res Intravaginal devices allowing for increased uptake of active ingredients
WO1999061062A1 (en) † 1998-05-29 1999-12-02 Massachusetts Institute Of Technology Cyclodextrin complexes
DE19830651A1 (de) * 1998-07-09 2000-01-13 Lohmann Therapie Syst Lts Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung
AU6517900A (en) 1999-08-03 2001-02-19 Smith & Nephew, Inc. Controlled release implantable devices
DE50112157D1 (de) * 2000-01-11 2007-04-19 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
US6299894B1 (en) † 2000-05-10 2001-10-09 Leiras Oy Drug delivery device, especially for the delivery of gestodene
WO2002032433A1 (en) 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
CN1536986B (zh) 2001-03-27 2012-07-04 沃纳奇尔科特(爱尔兰)有限公司 用于抗微生物剂给药的阴道内药物递送装置
CN1210079C (zh) 2001-04-25 2005-07-13 上海市计划生育科学研究所 阴道环制剂及其应用
PL367961A1 (en) 2001-08-31 2005-03-07 Schering Oy Drug delivery system
US8404272B2 (en) 2003-06-26 2013-03-26 Poly-Med, Inc. Fiber-reinforced composite rings for intravaginal controlled drug delivery
ES2442675T3 (es) † 2003-07-10 2014-02-12 Warner Chilcott (Ireland) Limited Dispositivos intravaginales de suministro de fármacos
JP2007530500A (ja) † 2004-03-24 2007-11-01 ナームローゼ・フエンノートチヤツプ・オルガノン ポリエチレン酢酸ビニル共重合体に基づく薬物送達システム
ATE372772T1 (de) 2004-07-13 2007-09-15 Schering Oy Retardiertes freigabesystem mit kontrollierter initialabgabe

Also Published As

Publication number Publication date
PL1629844T5 (pl) 2012-10-31
NO334931B1 (no) 2014-07-14
AU2005261682B2 (en) 2010-02-11
ZA200610473B (en) 2008-06-25
DK1629844T4 (da) 2012-05-29
IL179846A (en) 2012-07-31
PT1629844E (pt) 2007-10-17
US7850986B2 (en) 2010-12-14
DE602004008912D1 (de) 2007-10-25
BRPI0513295A (pt) 2008-05-06
UA91337C2 (ru) 2010-07-26
MX2007000433A (es) 2007-03-07
EP1629844A1 (de) 2006-03-01
NO20070805L (no) 2007-02-12
DE602004008912T3 (de) 2012-09-13
EP1629844B1 (de) 2007-09-12
KR20070035032A (ko) 2007-03-29
US20080031922A1 (en) 2008-02-07
SI1629844T1 (sl) 2007-12-31
RU2006145900A (ru) 2008-06-27
ES2293193T3 (es) 2008-03-16
EP1629844B2 (de) 2012-04-18
CA2569542A1 (en) 2006-01-19
CN1984639A (zh) 2007-06-20
DK1629844T3 (da) 2007-10-15
DE602004008912T2 (de) 2008-06-05
ES2293193T5 (es) 2012-06-13
IL179846A0 (en) 2007-05-15
PL1629844T3 (pl) 2008-02-29
WO2006005794A1 (en) 2006-01-19
AU2005261682A1 (en) 2006-01-19
CA2569542C (en) 2012-10-09
HK1086751A1 (en) 2006-09-29
JP4881861B2 (ja) 2012-02-22
RU2412693C2 (ru) 2011-02-27
NZ551823A (en) 2008-07-31
JP2008506672A (ja) 2008-03-06

Similar Documents

Publication Publication Date Title
NO20070805L (no) Medikamentavleveringssystem.
DE60040173D1 (de) Präsenz- und sitzungsbehandlungsinformationen
GB0705434D0 (en) Control systems and methods for active controlled bottomhole pressure systems
BRPI0509695B8 (pt) Sulfoximinas n-substituídas, composição e método para controlar insetos
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
WO2007150018A3 (en) Steroid-containing sustained release intraocular implants and related methods
DE50200579D1 (de) Kraftstoffsystem, verfahren zum betreiben des kraftstoff-systems, computerprogramm sowie steuer- und/oder regelgerät zur steuerung des kraftstoffsystems
EA200400774A1 (ru) Лечение атрофии мышц с помощью селективных модуляторов андрогенового рецептора
ATE495767T1 (de) Regelungsverfahren für die eluierung von therapeutischen wirkstoffen
TWI341362B (en) Saddle type vehicle, and engine controlling apparatus and idle stop canceling method for the saddle type vehicle
SE0203650D0 (sv) Pest controlling system
TW200631496A (en) One step fire ant control
MX2010003250A (es) Composicion y metodo de ingrediente sensible estabilizado.
DE502005004206D1 (de) Verwendung von 3-(2,4,6-trimethylphenyl)-4-neopentylcarbonyloxy-5,5-tetramethylen-dihydrofuran-2-on zur bekämpfung von psylliden
TWI315412B (en) Optical level control device, method for controlling same, and laser application device
HK1046367A1 (zh) 治疗过敏和炎症症状
FI20041572L (fi) Kasvihuone, kasvihuoneen ilmastonsäätöjärjestelmä ja menetelmä kasvihuoneen ilmaston säätämiseksi
MY152388A (en) Composition and method for controlling plant diseases
DK2004707T3 (da) Styret fordeling af aktive steder i Ziegler-Natta-katalysatorsystemer
TW200626162A (en) Agent for controlling demodicosis
GB2412549B (en) Call device, call control system, call management system, and call control method
ATE440353T1 (de) Ausfallsichere fernsteuerung
EP1693062A3 (de) Kontrolle der Androgen-Receptor abhängigen Gen-Exprimierung
DE602005025046D1 (de) Audioverwaltung in einer Dualprozessorumgebung
UA4196U (uk) Поліфіт-прополіс - біологічно активна домішка для профілактики та лікування інфекційних захворювань, туберкульозу, виразкової хвороби, підвищення імунітету

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1629844

Country of ref document: EP